Dynavax Technologies
DVAX
#4890
Rank
โ‚น161.87 B
Marketcap
โ‚น1,379
Share price
38.19%
Change (1 day)
26.04%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น25.54 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is โ‚น25.54 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น21.82 B2.05%
2023-12-31โ‚น21.38 B0.18%
2022-12-31โ‚น21.35 B11.45%
2021-12-31โ‚น19.15 B20.24%
2020-12-31โ‚น15.93 B3.22%
2019-12-31โ‚น15.43 B118.84%
2018-12-31โ‚น7.05 B
2014-12-31โ‚น0.60 B
2012-12-31N/A-100%
2011-12-31โ‚น0.67 B28.35%
2010-12-31โ‚น0.52 B-8.11%
2009-12-31โ‚น0.57 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
โ‚น4.10 B-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น590.67 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.708 T 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.235 T 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.924 T 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น2.138 T 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น5.453 T 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.530 T 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น4.892 T 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA